Cargando…

PI3Kδ Inhibition Enhances the Antitumor Fitness of Adoptively Transferred CD8(+) T Cells

Phosphatidylinositol-3-kinase p110δ (PI3Kδ) inhibition by Idelalisib (CAL-101) in hematological malignancies directly induces apoptosis in cancer cells and disrupts immunological tolerance by depleting regulatory T cells. Yet, little is known about the direct impact of PI3Kδ blockade on effector T c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bowers, Jacob S., Majchrzak, Kinga, Nelson, Michelle H., Aksoy, Bulent Arman, Wyatt, Megan M., Smith, Aubrey S., Bailey, Stefanie R., Neal, Lillian R., Hammerbacher, Jeffrey E., Paulos, Chrystal M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2017
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5626814/ https://www.ncbi.nlm.nih.gov/pubmed/29033940 http://dx.doi.org/10.3389/fimmu.2017.01221

Ejemplares similares

The Basics of Artificial Antigen Presenting Cells in T Cell-Based Cancer Immunotherapies
por: Neal, Lillian R., et al.
Publicado: (2017)

Human CD26(high) T cells elicit tumor immunity against multiple malignancies via enhanced migration and persistence
por: Bailey, Stefanie R., et al.
Publicado: (2017)

Identification of human CD4(+) T cell populations with distinct antitumor activity
por: Nelson, Michelle H., et al.
Publicado: (2020)

Toll-like receptor agonist therapy can profoundly augment the antitumor activity of adoptively transferred CD8(+) T cells without host preconditioning
por: Nelson, Michelle H., et al.
Publicado: (2016)

Ex vivo blockade of PI3K gamma or delta signaling enhances the antitumor potency of adoptively transferred CD8(+) T cells
por: Dwyer, Connor J., et al.
Publicado: (2020)

Cytokit: a single-cell analysis toolkit for high dimensional fluorescent microscopy imaging
por: Czech, Eric, et al.
Publicado: (2019)

Genomics meets immunity in pancreatic cancer: Current research and future directions for pancreatic adenocarcinoma immunotherapy
por: Bowers, Jacob S., et al.
Publicado: (2019)

Strategies to Overcome Failures in T-Cell Immunotherapies by Targeting PI3K-δ and –γ
por: Chandrasekaran, Sanjay, et al.
Publicado: (2021)

Adoptive Transfer of Ceramide Synthase 6 Deficient Splenocytes Reduces the Development of Colitis
por: Scheffel, Matthew J., et al.
Publicado: (2017)

Effective Activation and Expansion of Canine Lymphocytes Using a Novel Nano-Sized Magnetic Beads Approach
por: Szopa, Iwona Monika, et al.
Publicado: (2021)

CAR T Cells in Solid Tumors: Blueprints for Building Effective Therapies
por: Knochelmann, Hannah M., et al.
Publicado: (2018)

Computational Pipeline for the PGV-001 Neoantigen Vaccine Trial
por: Rubinsteyn, Alex, et al.
Publicado: (2018)

B cells imprint adoptively transferred CD8(+) T cells with enhanced tumor immunity
por: Smith, Aubrey S, et al.
Publicado: (2022)

Adoptive cell transfer: new perspective treatment in veterinary oncology
por: Bujak, Joanna Katarzyna, et al.
Publicado: (2018)

pileup.js: a JavaScript library for interactive and in-browser visualization of genomic data
por: Vanderkam, Dan, et al.
Publicado: (2016)

Synthetic RORγ agonists regulate multiple pathways to enhance antitumor immunity
por: Hu, Xiao, et al.
Publicado: (2016)

Th17 Cells in Cancer: The Ultimate Identity Crisis
por: Bailey, Stefanie R., et al.
Publicado: (2014)

The potential of adoptive transfer of γ9δ2 T cells to enhance blinatumomab’s antitumor activity against B-cell malignancy
por: Chen, Yun-Hsiang, et al.
Publicado: (2021)

The magic of small-molecule drugs during ex vivo expansion in adoptive cell therapy
por: Zhang, Hanwen, et al.
Publicado: (2023)

Initial dose of oncolytic myxoma virus programs durable antitumor immunity independent of in vivo viral replication
por: Flores, Erica B, et al.
Publicado: (2020)

Δ133p53α enhances metabolic and cellular fitness of TCR-engineered T cells and promotes superior antitumor immunity
por: Legscha, Kevin Jan, et al.
Publicado: (2021)

Enhanced antitumor immunity through sequential targeting of PI3Kδ and LAG3
por: Lauder, Sarah Nicol, et al.
Publicado: (2020)

Fundamentals of T Cell Metabolism and Strategies to Enhance Cancer Immunotherapy
por: Rangel Rivera, Guillermo O., et al.
Publicado: (2021)

Human Vδ2 versus non-Vδ2 γδ T cells in antitumor immunity
por: Kabelitz, Dieter, et al.
Publicado: (2013)

Fueling Cancer Immunotherapy With Common Gamma Chain Cytokines
por: Dwyer, Connor J., et al.
Publicado: (2019)

PiHelper: an open source framework for drug-target and antibody-target data
por: Aksoy, Bülent Arman, et al.
Publicado: (2013)

Chemotherapy weakly contributes to predicted neoantigen expression in ovarian cancer
por: O’Donnell, Timothy, et al.
Publicado: (2018)

Harnessing the Effect of Adoptively Transferred Tumor-Reactive T Cells on Endogenous (Host-Derived) Antitumor Immunity
por: Nesbeth, Yolanda, et al.
Publicado: (2010)

PaxtoolsR: pathway analysis in R using Pathway Commons
por: Luna, Augustin, et al.
Publicado: (2016)

Winging it: a qualitative study of knowledge-acquisition experiences for early adopting providers of medical assistance in dying
por: Winters, Janine Penfield, et al.
Publicado: (2022)

Generation of Antitumor T Cells For Adoptive Cell Therapy With Artificial Antigen Presenting Cells
por: Shrestha, Bishwas, et al.
Publicado: (2020)

Inheritance of Alcohol Abuse: Cross-Fitting Analysis of Adopted Men
por: Heath, Andrew C.
Publicado: (1995)

Exploring the mass adoption potential of wearable fitness devices in Malaysia
por: Hayat, Naeem, et al.
Publicado: (2023)

Adoption of Evidence-Based Health Promotion Programs: Perspectives of Early Adopters of Enhance(®)Fitness in YMCA-Affiliated Sites
por: Belza, Basia, et al.
Publicado: (2015)

RORgamma agonists enhance survival and memory of type 17 T cells and improve anti-tumor activity
por: Hu, Xiao, et al.
Publicado: (2015)

Adhesion analysis via a tumor vasculature-like microfluidic device identifies CD8(+) T cells with enhanced tumor homing to improve cell therapy
por: Camargo, Camila P., et al.
Publicado: (2023)

Mutations in an Innate Immunity Pathway Are Associated with Poor Overall Survival Outcomes and Hypoxic Signaling in Cancer
por: Olcina, Monica M., et al.
Publicado: (2018)

Transient Inhibition of PI3Kδ Enhances the Therapeutic Effect of Intravenous Delivery of Oncolytic Vaccinia Virus
por: Ferguson, Mark S., et al.
Publicado: (2020)

Tumor vessel-injuring ability improves antitumor effect of cytotoxic T lymphocytes in adoptive immunotherapy
por: Kanagawa, N, et al.
Publicado: (2013)

Host conditioning with IL-1β improves the antitumor function of adoptively transferred T cells
por: Lee, Ping-Hsien, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_0jpvkddvqvng2ohnkblitbl79h